SERUM LEPTIN AND PATHOLOGICAL FINDINGS AT THE TIME OF RADICAL PROSTATECTOMY
- 1 March 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 173 (3), 773-776
- https://doi.org/10.1097/01.ju.0000152619.96795.b2
Abstract
Purpose: Obesity has been associated with a higher risk of progression following radical prostatectomy (RP). Obese men have higher serum leptin, a hormone produced by adipocytes, which has also been shown to be an in vitro prostate cancer growth factor. We examined whether serum leptin correlates with advanced pathological findings at RP. Materials and Methods: Preoperative serum from 225 men treated with RP between 1998 and 1999 was examined for serum leptin. Multivariate logistic regression analysis was used to determine whether serum leptin was predictive of extraprostatic extension (pT3a). Results: Serum leptin highly correlated with body mass index (Spearman r = 0.602, p <0.001). Serum leptin was not associated with total or percent free prostate specific antigen (PSA), biopsy or prostatectomy Gleason score, age or height. On multivariate analysis with total and percent free PSA, clinical stage, age, biopsy Gleason score, body mass index, serum leptin, and height as variables considered for entry into the model, serum PSA (p = 0.009), clinical stage (p = 0.019) and serum percent free PSA (p = 0.041) were the only variables predictive of extraprostatic extension. Serum leptin was not significantly associated with pathological stage (pT3a). Conclusions: In the current study of predominantly white men with mainly low risk disease there was no statistically significant association between serum leptin and pathological stage (pT3a) at RP. In this cohort serum leptin was not a good biomarker for predicting advanced stage at RP.Keywords
This publication has 15 references indexed in Scilit:
- Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study GroupJournal of Clinical Oncology, 2004
- Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical ProstatectomyJournal of Clinical Oncology, 2004
- Prostate Cancer Cell-Adipocyte InteractionJournal of Biological Chemistry, 2003
- Differential effects of leptin on cancer in vitroJournal of Surgical Research, 2003
- The Underlying Basis for Obesity: Relationship to CancerJournal of Nutrition, 2002
- Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based StudyJNCI Journal of the National Cancer Institute, 2001
- Leptin and prostate cancerThe Prostate, 2001
- Recent Advances in Basic Obesity ResearchJAMA, 1999
- Leptin in relation to prostate cancer and benign prostatic hyperplasiaInternational Journal of Cancer, 1998
- Correlation of pathologic findings with progression after radical retropubic prostatectomyCancer, 1993